Elective lymph node dissection for melanoma (Q40717524)

23 September 2017

1 reference

title

Elective lymph node dissection for melanoma (English)

1 reference

23 September 2017

Lyons JH 3rd

1

1 reference

23 September 2017

Cockerell CJ

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

Journal of the American Academy of Dermatology

23 September 2017

published in

1 reference

23 September 2017

volume

30

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

467-480

1 reference

A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Axillary dissection in melanoma. Prognostic variables in node-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Malignant melanoma--introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

The role of elective lymph node dissection in melanoma: rationale, results, and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

"Prophylactic" lymph node dissection in melanoma: does it help?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Morbidity following prophylactic and therapeutic lymph node dissection for melanoma--a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Regional lymph node management and outcome in 100 patients with head and neck melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prognosis of clinical stage I melanoma patients with positive elective regional node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Stage I melanoma of the limbs. Immediate versus delayed node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

The role of the regional lymph node in breast cancer: a comparison between nodal and systemic reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Immunologic competence of regional lymph nodes in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Studies concerning the regional lymph node in cancer.II. Maintenance of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Possible role of uninvolved regional nodes in preventing metastasis from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A new sign of favorable prognosis in mammary cancer: hyperplastic reactive lymph nodes in the apex of the axilla

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Malignant melanoma. Practical considerations concerning prophylactic regional lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Results of regional lymph node dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Biostatistical basis of elective node dissection for malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Delayed node dissection in stage one malignant melanoma: justification and advantages

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

The Role of Groin Dissection in the Management of Melanoma of the Lower Extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Groin dissection in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Morbidity, mortality and local recurrence following regional node dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A rational approach to the surgical management of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Lymphoedema following ilio-inguinal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Current Management of Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Extent of lymph node dissection in melanoma of the trunk or lower extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Lymphedema after groin dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Isolated regional lymph node dissection: morbidity, mortality and economic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Comparison of lymphedema following incontinuity and discontinuity groin dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Early versus delayed shoulder motion following axillary dissection: a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Surgical management of regional lymph nodes in cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Tumor thickness as a guide to surgical management of clinical stage I melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Detection of Occult Lymph Node Metastases in Malignant Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Should elective lymph node dissection be used for treatment of primary melanoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Multivariate analysis. Some guidelines for physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Malignant melanoma prognostic factors 7: elective lymph node dissection.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Surgical management of malignant melanoma of the trunk and extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Immunolymphoscintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A technetium-labeled monoclonal antibody for imaging metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Management of the regional lymph nodes in patients with cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Isolated Limb Perfusion for Recurrent Melanoma of the Extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Natural history and selective management of in transit melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Hyperthermic adjuvant perfusion chemotherapy for stage I malignant melanoma of the extremity with literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

A prospective randomized study of regional extremity perfusion in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Hyperthermic isolation limb perfusion for malignant melanoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Lethal "thin" malignant melanoma. Identifying patients at risk

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

"Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

The prognostic significance of ulceration of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Ulceration and prognosis in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Thin malignant melanomas and recurrence potential

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

Cutaneous thick melanoma. Prognosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970057-5

7 January 2021

10.1016/S0190-9622(94)70057-5

Identifiers

DOI

1 reference

23 September 2017

1 reference